Skip to content

Join The Lazy Contractor's Blueprint live on Nov 28 — show up and get $50 in free Mindy creditsJoin The Lazy Contractor's Blueprint, free and live on Nov 28

Register free
Home/Contractors/Cellphire, INC.

Federal Contractor Profile

Cellphire, INC.

Federal contracting record: $126M obligated across 6 awards from 2 agencies, FY 2016–2026.

$126M
Total Obligated
6
Award Records
2
Agencies Served
4
NAICS Codes
OverviewContractsAgenciesNAICS

Company Profile

Parent UEI (Unique Entity Identifier)

F42VPQJ8LJL4

CAGE Code

48GV8

Registered Entities (UEIs)

2 under this organization

Address

9430 KEY WEST AVE STE 210, ROCKVILLE, MD, 208506325

First Federal Award

May 19, 2016

Most Recent Award

Nov 25, 2025

Federal Sales Analytics

Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.

Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).

Top Federal Agencies

Top NAICS Activity

  • 424210

    DRUGS AND DRUGGISTS' SUNDRIES MERCHANT WHOLESALERS

    1 awards

    $68M
  • 541715

    RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)

    3 awards

    $55M
  • 541714

    RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)

    1 awards

    $2.5M
  • 541712

    RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)

    1 awards

    $150K

Recent Federal Awards

DateAgencyNAICSDescriptionAmount
Mar 31, 2025Department of DefenseARMY MED RES ACQ ACTIVITY541715CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE$6.8M
Nov 27, 2024Department of DefenseARMY MED RES ACQ ACTIVITY541715CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE$9.1M
Mar 8, 2024Department of DefenseARMY MED RES ACQ ACTIVITY541715CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE$22M
Oct 11, 2023Department of DefenseARMY MED RES ACQ ACTIVITY541715CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE$1.1M
Aug 7, 2023Department of DefenseARMY MED RES ACQ ACTIVITY541714CLINICAL TRIAL IN SUPPORT OF TRAUMA INDICATIONS FOR LYOPHILIZED CANINE BLOOD PRODUCTS$759K
Apr 26, 2023Department of DefenseARMY MED RES ACQ ACTIVITY541715CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE$4.8M
Dec 22, 2022Department of DefenseW4PZ USA MED RSCH ACQUIS ACT541715CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE$208K
Aug 2, 2022Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA424210IGF::OT::IGF FOR OTHER FUNCTIONSCELLPHIRE$3.5M
Aug 2, 2022Department of DefenseW4PZ USA MED RSCH ACQUIS ACT541715CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE$657K
May 10, 2022Department of DefenseW4PZ USA MED RSCH ACQUIS ACT541715CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE$2.9M
Oct 8, 2021Department of DefenseW4PZ USA MED RSCH ACQUIS ACT541714CLINICAL TRIAL IN SUPPORT OF TRAUMA INDICATIONS FOR LYOPHILIZED CANINE BLOOD PRODUCTS$252K
Apr 2, 2021Department of DefenseW4PZ USA MED RSCH ACQUIS ACT541715CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE$3.8M
Jan 26, 2021Department of DefenseW4PZ USA MED RSCH ACQUIS ACT541715CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE$1.1M
Sep 29, 2020Department of DefenseW6QK ACC-APG DURHAM541715LYOPHILIZED CANINE PLASMA SEQUENTIAL PHASE II$1.1M
Jun 17, 2020Department of DefenseW4PZ USA MED RSCH ACQUIS ACT541715CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE$2.8M
May 28, 2020Department of DefenseW4PZ USA MED RSCH ACQUIS ACT541714CLINICAL TRIAL IN SUPPORT OF TRAUMA INDICATIONS FOR LYOPHILIZED CANINE BLOOD PRODUCTS$241K
May 1, 2020Department of DefenseW4PZ USA MED RSCH ACQUIS ACT541714CLINICAL TRIAL IN SUPPORT OF TRAUMA INDICATIONS FOR LYOPHILIZED CANINE BLOOD PRODUCTS$1.5M
Apr 13, 2020Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA424210IGF::OT::IGF FOR OTHER FUNCTIONSCELLPHIRE$33M
Feb 28, 2020Department of DefenseW4PZ USA MED RSCH ACQUIS ACT541715CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE$2.1M
Feb 18, 2020Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA424210IGF::OT::IGF FOR OTHER FUNCTIONSCELLPHIRE$1.3M
Dec 19, 2019Department of DefenseW4PZ USA MED RSCH ACQUIS ACT541715CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE$2.6M
Jul 16, 2019Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA424210IGF::OT::IGF FOR OTHER FUNCTIONSCELLPHIRE$2.8M
Sep 27, 2018Department of DefenseW6QK ACC-APG DURHAM541715FREEZE DRIED PLASMA FOR CANINES$999K
Jan 10, 2017Department of DefenseHQUSSOCOM541712IGF::OT::IGF FEASIBILITY STUDY, SBIR PHASE I, TOPIC SOCOM163-007, FREEZE DRIED PLASMA FOR CANINES$150K
Dec 15, 2016Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA424210IGF::OT::IGF FOR OTHER FUNCTIONSCELLPHIRE$25M

Want to win work like Cellphire, INC.?

Their contracts will eventually end — and when they do, the government has to award that work again. Mindy tells you up to a year early, so you can be ready to compete for it.